What Controls Should Insurers Use for AI Underwriting Decisions in 2026?

The Direct Answer: AI Underwriting Controls

The best answer is a documented control system that defines who may allow an AI model to recommend, approve, bind, or change an insurance decision. Controls should cover data quality, model performance, bias and proxy discrimination, explainability, human authority, security, change management, monitoring, incident response, and independent validation. As of 26 September 2026, the defensible position is not that AI is automatically safe or unsafe, but that its authority must match its evidence, environment, and ability to be monitored.

Also worth reading: Who Should Control Autonomous AI Decisions in Insurance Underwriting, and What Should Govern Them? · Bounded Autonomous Underwriting Controls: What They Are and How to Implement Them in 2026? · How Will AI Underwriting Regulatory Compliance Evolve for Insurers by 2027?

AI underwriting controls should ordinarily sit above four operational layers: data controls, model controls, workflow controls, and governance controls. A mature program also preserves an accountable human path for unusual cases, records the information used at decision time, and defines what happens when a model drifts or produces an anomalous result. A policy document alone is insufficient. Insurers need evidence that the control operates in production, including sample decisions, exception reports, override rates, model versions, and signed approvals.

Research supplied for this article reports that 83% of insurers support AI for repeatable work while 75% demand controls. That combination is an important signal: adoption and caution are happening together rather than as opposing strategies. Insurers appear willing to automate bounded activities, but many do not want an opaque system to exercise unrestricted authority over customers. The practical objective is therefore controlled decision authority, not maximum automation.

How AI Underwriting Controls Work

A control begins when a proposed use case is classified by its decision impact. Low-impact tasks might include extracting policy information, flagging a missing document, or routing a straightforward submission. Higher-impact tasks include setting a price, declining an application, determining eligibility, or selecting which applicants receive manual review. The classification determines the required evidence, approval level, testing depth, and whether a human must make the final decision.

During data intake, insurers test whether the training and evaluation data are relevant, accurate, lawfully available, and representative of the current book. Credit-like variables require particular scrutiny because historical decisions can reproduce earlier access or pricing patterns. During model validation, performance is measured by use case rather than by one universal accuracy score. False-positive and false-negative rates, calibration, segment-level results, stability over time, and performance under data shift should be considered. Accuracy alone can conceal unacceptable outcomes for a small but important group.

At workflow level, each model recommendation should expose its status. A recommendation, an auto-decision, and a human override are different actions and should not share the same approval label. Controls should specify the permitted action, the monetary or coverage limits, the model version, the data snapshot, the reason codes, and the person or committee responsible for the outcome. If the model falls outside validated conditions—for example, it encounters an unfamiliar business class or a confidence level below an approved threshold—the system should route the case to review rather than forcing a decision.

Independent validation is the final line of defense, but it should not be the first. Model developers cannot be the only judges of whether their own systems are dependable. A separate risk, actuarial, compliance, legal, or internal-audit function should test design assumptions, implementation, outcomes, and governance. The independent review should be capable of stopping deployment, restricting authority, or requiring remediation, rather than merely documenting a concern.

Governance and Human Decision Authority

The central governance question is not “Can the model predict?” but “Who is authorized to let it act?” Every production use case should have a named business owner, a model owner, a control owner, and an escalation owner. A committee may authorize the system, but that does not remove accountability from the insurer. The organization must preserve records showing who approved the model, the version, the threshold, the market scope, and any exceptions.

Human involvement must be meaningful. A reviewer who receives dozens or hundreds of exceptions without enough time, context, or authority is not a substantive safeguard. Insurers should monitor reviewer capacity, queue times, disagreement rates, override rates, and cases that no one challenges. If reviewers routinely accept AI output, their role may be ceremonial; if they reverse nearly every recommendation, the automation claim may be overstated. A useful review standard combines authority, competence, time, access to supporting evidence, and documented reasons for disagreement.

Risk appetite should be translated into operating thresholds. The organization might prohibit fully automated decisions for particular classes, set a maximum bound authority for lower-risk submissions, or require dual approval for large limits. Thresholds can include minimum data completeness, maximum exception rate, minimum sample size by segment, acceptable calibration error, maximum review backlog, and maximum allowable model drift. These numbers should reflect the carrier’s own portfolio and cannot responsibly be reduced to a universal industry standard.

AI governance also needs a change-control trigger. A new data source, revised feature, altered model, expanded geography, or integration with a new system can change risk even when the model code is unchanged. The insurer should maintain a production inventory and connect it to release management. Any material change should trigger impact analysis, regression testing, approval, and a controlled rollout. A 30-day pilot without an inventory may generate useful information, but it is not evidence of enterprise-wide governance.

Data, Bias, Security, and Model-Risk Controls

Data controls should begin with a documented purpose for each variable. Underwriting systems may combine application data, external records, prior claims, geospatial information, device data, and behavioral features. Each source needs an owner, a quality measure, a lawful-use assessment, a retention rule, and a response plan when availability falls below the validated requirement. Missing data should not silently become a favorable or unfavorable signal.

Fairness testing should examine both protected characteristics and proxies where use of the characteristic is legally or ethically appropriate. Aggregate results can hide concentrated harm, so evaluation should cover relevant customer groups, product lines, distribution channels, and decision stages. Insurers should not assume that removing race or sex from a dataset eliminates bias; proxies and historical outcomes may still produce uneven pricing, offers, denials, referrals, or service times. Testing must be paired with an investigation process, because a disparity is a signal requiring review rather than proof of unlawful conduct.

Security controls address confidentiality, integrity, availability, and provenance. Insurer files contain sensitive personal, health, financial, and commercial information, so access should follow least-privilege principles and be logged. APIs and agent workflows require authentication, authorization, rate limits, prompt or instruction controls where applicable, and protection against manipulation. Because an AI agent can call other systems, a written model-risk policy is not enough; technical permissions must limit what data it can read and what actions it can take.

Model monitoring should compare production behavior with validation expectations. Dashboards can track input drift, missing fields, output distribution, approval rate, referral rate, claims performance, customer complaints, and manual overrides. The chosen metrics should reflect the time horizon of the business. A claim may take years to develop, so an apparently stable decision model may still hide long-tail pricing risk. Thresholds should trigger investigation, not automatically erase a model; a spike can result from market movement, a system outage, or an emerging fraud pattern.

Comparing Control Approaches

Insurers have several credible approaches, but they differ in cost, speed, and risk transfer. The following comparison is conceptual; actual vendor, carrier, and regulatory requirements determine the final design.

A rules-based approach is not automatically conservative. Old rules can reproduce historical discrimination, be difficult to maintain, or generate brittle outcomes. Conversely, an AI system is not automatically superior because it handles unstructured information. Traditional methods may remain preferable where sample sizes are small, decisions are legally sensitive, inputs are unstable, or accountability cannot be clearly assigned.

Automation levels should be earned through evidence. A carrier might begin with document extraction, progress from recommendation to advisory support, and permit auto-processing only for submissions that remain within tested conditions. This staged path increases short-term expense and may delay benefits, but it limits the chance that production scale outruns governance. The “right” model is the one whose risk is acceptable for a defined use—not the most technically advanced model available.

Practical Implementation Steps

Start with a use-case inventory and decision map. Identify every place AI influences intake, data enrichment, pricing, eligibility, fraud screening, referral, binding, or claims linkage. For each use case, record the business owner, affected customers, decision authority, data sources, external vendors, model version, validation status, and monitoring rules. This creates the foundation for deciding which systems deserve independent review and which activities remain ordinary software configuration.

Next, establish a risk tier before procurement or deployment. Tier one can cover clerical assistance; tier two can cover recommendations affecting case routing; tier three can cover pricing or acceptance decisions; and the highest tier can cover fully automated customer-facing outcomes. Governance requirements should increase with the tier. A carrier does not need an elaborate committee for harmless text extraction, but an AI decline or price decision warrants substantially more scrutiny.

The carrier should then document the decision contract. It should state what the system may do, what it must not do, how confidence is used, what happens at a threshold, and who can override it. Data lineage, validation datasets, test results, known limitations, and approval history should be linked to the production version. A concise one-page record for every model is more useful than a large policy that no operator can apply.

Implementation should include adversarial testing, not only historical back-testing. The team should test incomplete records, changed formats, duplicate identities, unusual values, cyber failures, model downtime, and deliberately manipulated instructions where agents are involved. Results should be reproducible from a fixed dataset and model version. Before launch, the carrier should rehearse rollback, vendor outage, regulatory inquiry, customer remediation, and model suspension. The first 30 to 90 days of production should use tightened limits and frequent review, with expansion occurring only when evidence supports it.

Cost estimates must include control work. Vendors may quote low or no platform prices, but an enterprise deployment can require data preparation, integration, security review, actuarial analysis, legal review, validation, change management, and ongoing monitoring. Internal staffing can run from several full-time-equivalent roles in a large program to part-time participation in a smaller carrier, while an external validation package may be quoted as a fixed project or recurring service. A small pilot might cost tens of thousands of dollars; a multi-carrier production program can reach hundreds of thousands or more. These are planning ranges, not vendor prices, and savings should be measured against the full lifecycle cost rather than model fees alone.

Common Mistakes and Warning Signs

A common mistake is equating accuracy with suitability. A model can predict historical decisions accurately while reproducing unfair constraints, weak data, or an obsolete business strategy. Another mistake is validating a notebook and then deploying a different production pipeline. Inputs can change during integration, missing-value behavior can differ, and a feature store can serve a newer dataset than the one tested. Validation must examine the real decision path and the real release.

Organizations also overstate human oversight. Adding a “human in the loop” label does not establish meaningful review if the employee lacks time or authority. Override patterns deserve attention: very low rates may indicate rubber-stamping, while very high rates may indicate that the model is not fit for its assigned role. Reviewers should receive understandable reasons, uncertainty information, and the evidence required to disagree, while still being prevented from introducing unsupported discriminatory factors.

Documentation without enforcement is another failure. Policy owners should define escalation paths, minimum evidence, stop conditions, and consequences for bypassing controls. Audit rights over vendors, access to logs, notification of material model changes, and secure data return or deletion should be contractual. Insurers that cannot identify the current production model, reconstruct a decision, or stop a faulty release are not operating a mature control framework.

Finally, leaders should resist indiscriminate speed targets. Processing more applications per hour can be counterproductive if the model quietly lowers referral quality, increases complaints, or misses emerging losses. Monitor business outcomes as well as operational efficiency. A pilot should have a predetermined success date—often three to six months for operational evaluation—and should not be expanded solely because software was delivered on schedule. Risk evidence should determine broader use.

When to Act and What Good Looks Like

An insurer should act now if AI is already connected to a live workflow, especially when the system can affect price, eligibility, acceptance, capacity, or referrals. Waiting until a large enterprise program is complete can let uncontrolled decisions accumulate. A faster initial response can be a two-week inventory of models, data sources, vendors, owners, and live decision points, followed by immediate restrictions on unsupported high-impact automation.

Broader deployment should wait until data lineage is documented, decision authority is assigned, segment-level testing is available, and independent validation is complete. The carrier should be able to reproduce a sample decision, identify the model version, show why an exception was sent to review, and demonstrate rollback. It should also have thresholds for degraded performance and a tested procedure for customer notification and remediation where necessary.

Good governance does not mean preventing every innovation. It creates permission to innovate within known limits and a reliable way to revoke that permission when conditions change. The insurer can automate repeatable, lower-impact work while reserving greater human judgment for novel, disputed, or high-impact cases. That balance is more credible than a blanket promise that AI is safe or a blanket fear that all AI is dangerous.

By 2026, AI underwriting controls are becoming part of operating infrastructure, not an optional ethics statement. The research context cites 83% insurer support for AI in repeatable work, 75% demand for controls, and growing enterprise attention to governance, data readiness, and independent risk assessment. The competitive advantage will belong to carriers that connect technical performance to decision authority and can show that the system works as intended. For brokers and technology buyers, the decisive question is therefore simple: can the insurer explain, reproduce, monitor, and stop every consequential AI underwriting decision?